Home / Treatments / Diskectomy
Diskectomy denials: what the review data shows
Independent reviewers have decided 57 published cases where an insurer denied Diskectomy — and they overturned the insurer 17.5% of the time. A denial for Diskectomy is a starting position, not a final answer.
Published decisions
57
2001–2026
Overturned
17.5%
10 denials reversed
Conditions behind diskectomy denials
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Vertebral Disc Prob | 29 | 20.7% |
| Back Pain | 15 | 6.7% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 33 | 30.3% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 23 | 0% |
Typical time to a decision
19 days
Most land between 7 and 21 days
Handled as urgent
33.3%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for cervical spine surgery (artificial disc replacement at C4-5 and C5-6 and foraminotomy with anterior cervical discectomy and fusion (ACDF) at C7-T1). Findings: The physician reviewer found that Boddapati and colleagues have noted that many patients with multilevel disease are not good candidates for cervical disc arthroplasty (CDA) at all levels. For such patients, hybrid surgery, a combination of adjacent anterior cervical discectomy and fusion (ACDF) and CDA, may be more appropriate. They concluded that patients undergoing hybrid surgery are not at increased risk of perioperative complications relative to a 2-level ACDF and may benefit from shorter length of stay.
Nature of Statutory Criteria/Case Summary: An enrollee has requested coverage for L4-5 artificial disc replacement. Findings: The physician reviewer found that there is sufficient support for the requested services in this patient’s case. The U.S. Food and Drug Administration (FDA) approval for the ProDisc-L total disc replacement states that this device is indicated for spinal arthroplasty in patients who are skeletally mature, have degenerative disc disease at one level in the lumbar spine from L3 to S1, have no more than grade 1 spondylolisthesis at the involved level, and have had no pain relief after at least six months of non-surgical treatment. FDA exclusions include bony lumbar spinal stenosis and isolated radicular compression syndromes, especially due to disc herniation.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for total disc arthroplasty procedure. The U.S. Food and Drug Administration (FDA) has approved ProDisc-L total disc replacement for treatment of up to two consecutive levels from L3 to S1. The FDA further notes that the patient should be skeletally mature with no spinal growth remaining, have a condition in which pain is caused by wear-and-tear on a spinal disc at one or two consecutive levels in the lumbar spine from L3 to S1, have no more than grade 1 spondylolisthesis at the involved level(s), and have failed at least six months of conservative treatment.
Physician 1: The patient is a 26-year-old male with a history of low back pain and radicular symptoms to both legs, dating back to 2001. Conservative treatment had not been effective. MRI showed disc protrusions at L4-5 and L5-S1, but no frank nerve root compression and no clinical neurological deficits were described. Two-level endoscopic discectomy/thermal annuloplasty at L4-5 and L5-S1 was recommended by the patient’s provider and carried out In March 2006. The patient requested reimbursement from the Health Plan for the costs incurred. The Health Plan denied the patient’s request stating that percutaneous techniques for lumbar, thoracic or cervical discs, with or without endoscopic guidance, are considered investigational and were therefore not a covered benefit.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Diskectomywhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.